Welltower (WELL)
(Delayed Data from NYSE)
$133.27 USD
-1.61 (-1.19%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $133.29 +0.02 (0.02%) 7:58 PM ET
2-Buy of 5 2
F Value C Growth B Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$133.27 USD
-1.61 (-1.19%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $133.29 +0.02 (0.02%) 7:58 PM ET
2-Buy of 5 2
F Value C Growth B Momentum D VGM
Zacks News
What's Going On With Block Shares?
by Derek Lewis
Block shares are making headlines for all the wrong reasons today, with short-seller Hindenburg Research raising red flags surrounding the company. Whose side are you on?
Welltower (WELL) Down 9.2% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Welltower (WELL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is it Wise to Hold on to Healthpeak (PEAK) Stock for Now?
by Zacks Equity Research
Healthpeak's (PEAK) focus on enhancing its life-science real-estate assets, capital-recycling moves and a solid balance sheet bodes well. Stiff competition from peers and rising interest rates are woes.
Welltower (WELL) Q4 FFO & Revenues Beat, SHO Occupancy Rises
by Zacks Equity Research
Welltower's (WELL) Q4 results gain on better-than-anticipated revenues. The SHO portfolio occupancy improves year over year. The company issues its 2023 outlook.
Welltower (WELL) Surpasses Q4 FFO and Revenue Estimates
by Zacks Equity Research
Welltower (WELL) delivered FFO and revenue surprises of 1.22% and 1.39%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Welltower (WELL) to Post Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Positive operating trends in the SHO portfolio are likely to have aided Welltower's (WELL) Q4 earnings. However, rising interest rates and a stronger U.S. dollar might have been a spoilsport.
Is it Wise to Hold on to Welltower (WELL) Stock for Now?
by Zacks Equity Research
Welltower's (WELL) diversified portfolio of healthcare assets, strategic repositioning efforts and strong balance sheet bode well. Stiff competition and rising interest rates are key concerns.
Welltower (WELL) Rallies 15% in Past Three Months: Here's Why
by Zacks Equity Research
Welltower's (WELL) restructuring initiatives, improving seniors housing operating portfolio fundamentals and capital recycling efforts drive a 15% increase in its share price.
Welltower (WELL) Closes First Tranche of JV With Integra
by Zacks Equity Research
Welltower (WELL) enters a master lease with Integra for the entire 147-property skilled nursing portfolio. It also sells 15% interest in 54 skilled nursing assets to Integra for $73 million.
Welltower (WELL) Up 2.5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Welltower (WELL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should Vanguard MidCap Value ETF (VOE) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VOE
Welltower (WELL) Q3 FFO Meets, Revenues Top, Same-Store NOI Up
by Zacks Equity Research
Welltower (WELL) reports healthy Q3 results, with the top line growing year over year. The SHO portfolio witnesses improvement in occupancy. WELL's total same-store NOI increases year over year.
Welltower (WELL) Matches Q3 FFO Estimates
by Zacks Equity Research
Welltower (WELL) delivered FFO and revenue surprises of 0% and 1.11%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Uniti Group (UNIT) Q3 FFO and Revenues Beat Estimates
by Zacks Equity Research
Uniti (UNIT) delivered FFO and revenue surprises of 2.38% and 0.26%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Braemar Hotels & Resorts (BHR) Q3 FFO and Revenues Lag Estimates
by Zacks Equity Research
Braemar Hotels & Resorts (BHR) delivered FFO and revenue surprises of -20% and 0.61%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Welltower (WELL) This Earnings Season?
by Zacks Equity Research
Positive operating trends in the SHO portfolio are likely to have aided Welltower's (WELL) Q3 earnings. However, a delay in the disbursements of HHS funds and interest rate hikes might have been deterrents.
NETSTREIT (NTST) Q3 FFO and Revenues Beat Estimates
by Zacks Equity Research
NETSTREIT (NTST) delivered FFO and revenue surprises of 7.14% and 0.65%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
American Tower (AMT) Surges 3.3%: Is This an Indication of Further Gains?
by Zacks Equity Research
American Tower (AMT) was a big mover last session on higher-than-average trading volume. The latest trend in FFO estimate revisions might help the stock continue moving higher in the near term.
Welltower (WELL) to Witness a Dim Q3 Amid Delayed HHS Funds
by Zacks Equity Research
Despite a healthy occupancy trend in the seniors housing operating (SHO) portfolio, Welltower (WELL) is likely to experience Q3 FFO below the midpoint of its guidance due to delayed HHS funds.
Should Vanguard MidCap Value ETF (VOE) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VOE
Should Investors Retain Welltower (WELL) Stock for Now?
by Zacks Equity Research
Rise in healthcare expenditure by an aging population and strategic acquisitions are likely to aid Welltower (WELL). Stiff competition and earnings dilution in the near term from asset sales are woes.
Innovative Industrial Properties (IIPR) Stock Jumps 11.9%: Will It Continue to Soar?
by Zacks Equity Research
Innovative Industrial Properties (IIPR) was a big mover last session on higher-than-average trading volume. The latest trend in FFO estimate revisions might not help the stock continue moving higher in the near term.
Welltower (WELL) Witnesses Occupancy Gains in Seniors Housing
by Zacks Equity Research
Welltower's (WELL) seniors housing occupancy gains traction in Q2, led by its U.S. and U.K. portfolios. Management's outlook remains robust based on the seniors housing operating portfolio recovery.
Welltower (WELL) Q2 FFO & Revenues Beat, SHOP Occupancy Up
by Zacks Equity Research
Welltower's (WELL) Q2 results outpace estimates with solid top-line growth. The seniors housing operating portfolio occupancy witnesses significant improvements year over year.
Welltower (WELL) Tops Q2 FFO and Revenue Estimates
by Zacks Equity Research
Welltower (WELL) delivered FFO and revenue surprises of 1.18% and 3.46%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?